Amsterdam Molecular Therapeutics to Appoint George Morstyn to Supervisory Board
AMSTERDAM, The Netherlands, April 2 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that AMT's Supervisory Board has…